Fundraising Fox

Oliver Rosen, M.D.

Executive at Deciphera Pharmaceuticals

Cambridge, Massachusetts, United States

Find your path to Oliver

554 people in our graph share verified history with Oliver — schools, employers, funds. One of them is your warm intro.

Mitch KaporunlockedOliver: together at MIT Sloan School of Management (2025)
Oliver: together at Deciphera
×6Oliver: together at Amgen Inc.
×2Oliver: together at University of Cologne

Executive at Deciphera Pharmaceuticals

Intro paths

→

In turn, Oliver can intro founders to Deciphera Pharmaceuticals's investors below.

Deciphera Pharmaceuticals's investors · 3

Frazier Life SciencesPalo Alto · since 2017REDMILESan Francisco · since 2017Viking Global InvestorsStamford · since 2017

Co-founders at Deciphera Pharmaceuticals

DF
Daniel F. Flynn, Ph.D.Executive Officer

Experience

  1. Akamis BioChief Medical Officercurrent2023 — presentCambridge, MA
  2. Kernal BiologicsMember of Advisory Boardcurrent2023 — present
  3. Community ServingsMember, Board of Mentorscurrent2018 — present
  4. Community ServingsMember Board Of Directors2015 — 2018Jamaica Plain, MA
  5. DynamiCure BiotechnologyPresident and Chief Medical Officer2022 — 2023Waltham, MA
  6. DynamiCure BiotechnologyChief Medical Officer2021 — 2022Waltham, Massachusetts, United States
  7. SQZ BiotechnologiesSAB Member2021 — 2022
  8. SQZ BiotechnologiesChief Medical Officer2019 — 2021
  9. Deciphera PharmaceuticalsChief Medical Officer2014 — 2018Cambridge, Massachessetts
  10. Millennium PharmaceuticalsVice President US & Global Medical Affairs2010 — 2014Cambridge, Massachessetts
  11. Millennium PharmaceuticalsSenior Medical Director2009 — 2010
  12. GenentechSenior Medical Director2008 — 2009
  13. Genentech Inc.Medical Director2006 — 2008
  14. Amgen Inc.Associate Director Medical Affairs2004 — 2006
  15. Hoffmann-La RocheClinical Scientist2003 — 2004
  16. Merck KGaAGlobal Project Physician2001 — 2003

Skills & more

Cross-functional Team LeadershipManagementStrategic PlanningMolecular BiologyTranslational ResearchHealthcareMedical ResearchMentoringLeadershipMedical AffairsMedical WritingOncology
+12 moreCancerBiotechnologyDrug DevelopmentDrug DiscoveryBiopharmaceuticalsClinical DevelopmentMedicineClinical ResearchImmunologyPharmaceutical IndustryGlobal Drug DevelopmentLifesciences
  • Executive Certificate in Digital Business — MIT Sloan School of Management
  • Interpersonal Communication: Strategies for Executives — MIT Sloan School of Management
  • Artificial Intelligence: Implications for Business Strategy — MIT Sloan School of Management
  • Transforming Healthcare with Artificial Intelligence — MIT Sloan School of Management
  • Artificial Intelligence in Pharma and Biotech — MIT Sloan School of Management

From Oliver's professional profile.

Frequently asked questions

Who is Oliver Rosen, M.D.?
Executive Officer at Deciphera Pharmaceuticals
Where does Oliver Rosen, M.D. work?
Oliver Rosen, M.D. is Executive at Deciphera Pharmaceuticals.
Where did Oliver Rosen, M.D. go to school?
Oliver Rosen, M.D. studied at MIT Sloan School of Management (Executive Certificate in Digital Business); Humboldt-Universität zu Berlin (Hematology & Oncology); University of Hamburg (Post-Doctoral Program, Molecular Biology).

Same school

Also attended MIT Sloan School of Management935

Doug LeonePartner at Sequoia Capital; former Global Managing PartnerHemant TanejaCEO & Managing Director of General CatalystBrad FeldCo-founder of Foundry and TechstarsChris MorrisProcess Specialist, Exit Readiness at Mayfair Equity PartnersBirgitteInvestor at InvestinorOlaInvestor at Investinor

+ 929 more

Also attended Humboldt-Universität zu Berlin99

Theresa TongOperations Manager at FusionEvaLegal at NAPSusanna SzwajaWorkplace Managerin & Event Support at RedstoneJana GranigSenior Finance Manager at FoodLabsIsabelle ThierfelderSenior Investment Manager at Seed+SpeedNelly KarschAssociate at Seed+Speed

+ 93 more

Also attended University of Hamburg91

Andreas WeiskamPartner and Co-Founder of Sapphire Ventures, focused on European investmentsLucas De FourLegal Manager at Hummingbird VenturesFernanda BartelsInvestor at Extantia CapitalAndrew KozlovManaging Partner at 4BIO CapitalJennifer SchoeberleinPartner, ESG & Impact at Sawari VenturesIskender DirikPartner at Delin Ventures

+ 85 more

Also attended University of Cologne120

Andrea GazviniAssociate at NorthzoneJohann FriederichAssociate at Notion CapitalPatrick MeisbergerManaging Partner at CommerzVenturesAlex PortoInvestor at Riverwood CapitalNicolas El BazeSenior Advisor at Partech VenturesMarkus MerzInvestment Manager at Capnamic

+ 114 more

Shared employers

Also worked at Akamis Bio5

Maina BhamanPartner at Sofinnova PartnersAntonio PostigoCSO at StratosvirNIGEL CROCKETTExecutive Officer at BicyclePhil L'HuillierChief Executive Officer at Scancell Holdings PlcJohn BeadleCo-founder at Vitarka Therapeutics

Also worked at Kernal Biologics5

Umut EserVenture Partner at Magnetic VenturesYusuf ErkulFounder at Kernal BiologicsJeff OzdemirFounder at Kernal BiologicsBurak YilmazFounder at Kernal BiologicsCatherine MoroskiExecutive Officer, Director at Kernal Biologics

Also worked at Genentech245

David SchenkeinInvestor at GV (Google Ventures)Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Marco PrunottoInvestor at MedicxiLogan HilleLife Sciences Analyst at CincyTechJosephine ChenInvestor at Sequoia CapitalAbbie CelnikerInvestor at Third Rock Ventures

+ 239 more

Also worked at Amgen Inc.189

Parker ConradCo-founder & CEO of RipplingSeth LieblichInvestment Team at 8VCSean BruichChief Technology Officer at Flare Capital PartnersSteph ScottVice President at Questa CapitalBeth SeidenbergFounding Managing Director at Westlake Village BioPartnersKelli McKeirnanDirector of Administration at Westlake Village BioPartners

+ 183 more